Can your genes prevent bad drug reactions? new study aims to find out
NCT ID NCT06219720
First seen Nov 01, 2025 · Last updated Jun 20, 2026 · Updated 32 times
Summary
This pilot study is testing whether genetic testing (pharmacogenomics) can help reduce harmful drug reactions in people taking five or more medications. Researchers will analyze participants' DNA and use a special computer dashboard to suggest safer drug combinations. The study involves 50 adults aged 45 and older and will also track emergency room visits and hospital stays.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVERSE DRUG REACTION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
The Interprofessional Pharmacogenomics (IPGx) Clinic
RECRUITINGBryan, Texas, 77802, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact
Contact
Contact
Contact
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
pharmacogenomic testing and clinical decision support dashboard
What this could lead to
If successful, this could lead to a tool that helps doctors personalize medication choices to reduce side effects and hospital visits.
What could go wrong
This is a very small pilot study (50 people) focused on feasibility, not on proving effectiveness. Results may not apply to broader populations.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.